BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
American Superconductor
AMSC
$2.54B
| $304K | ﹤0.01% |
12,339
-10,340
| -46% | -$255K |
|
2652
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.35B
| $303K | ﹤0.01% |
6,100
+3,379
| +124% | +$168K |
|
2653
Arcus Biosciences
RCUS
$1.23B
| $303K | ﹤0.01% |
20,341
+9,016
| +80% | +$134K |
|
|
THRD
2654
DELISTED
Third Harmonic Bio
THRD
| $303K | ﹤0.01% |
+29,431
| New | +$303K |
|
2655
Bank of Marin Bancorp
BMRC
$398M
| $302K | ﹤0.01% |
12,710
+9,303
| +273% | +$221K |
|
2656
Utah Medical Products
UTMD
$200M
| $302K | ﹤0.01% |
4,912
+3,795
| +340% | +$233K |
|
2657
MacroGenics
MGNX
$100M
| $302K | ﹤0.01% |
92,859
+2,080
| +2% | +$6.76K |
|
2658
Vimeo
VMEO
$1.28B
| $302K | ﹤0.01% |
+47,148
| New | +$302K |
|
2659
Towne Bank
TOWN
$2.83B
| $301K | ﹤0.01% |
8,846
-10,866
| -55% | -$370K |
|
2660
Omnicell
OMCL
$1.46B
| $301K | ﹤0.01% |
6,754
-33,417
| -83% | -$1.49M |
|
2661
Gates Industrial
GTES
$6.6B
| $300K | ﹤0.01% |
14,591
+7,745
| +113% | +$159K |
|
2662
Phinia Inc
PHIN
$2.26B
| $299K | ﹤0.01% |
+6,204
| New | +$299K |
|
2663
Lennar Class B
LEN.B
$34B
| $299K | ﹤0.01% |
2,379
-2,902
| -55% | -$364K |
|
2664
Wolverine World Wide
WWW
$2.48B
| $299K | ﹤0.01% |
13,446
-28,140
| -68% | -$625K |
|
|
NBIS
2665
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.6B
| $298K | ﹤0.01% |
10,776
-90,984
| -89% | -$2.52M |
|
2666
Expro
XPRO
$1.43B
| $298K | ﹤0.01% |
+23,921
| New | +$298K |
|
2667
Deutsche Bank
DB
$71.6B
| $297K | ﹤0.01% |
17,438
-223,841
| -93% | -$3.82M |
|
2668
First Commonwealth Financial
FCF
$1.84B
| $297K | ﹤0.01% |
17,565
-17,327
| -50% | -$293K |
|
|
MAGN
2669
Magnera Corporation
MAGN
$393M
| $297K | ﹤0.01% |
+16,349
| New | +$297K |
|
2670
Amplitude
AMPL
$1.47B
| $297K | ﹤0.01% |
+28,146
| New | +$297K |
|
2671
NCR Voyix
VYX
$1.77B
| $296K | ﹤0.01% |
21,420
-78,192
| -78% | -$1.08M |
|
|
NAGE
2672
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $296K | ﹤0.01% |
55,879
-17,393
| -24% | -$92.3K |
|
2673
Openlane
KAR
$3.07B
| $296K | ﹤0.01% |
14,931
-8,958
| -37% | -$178K |
|
2674
ProShares Ultra Gold
UGL
$744M
| $296K | ﹤0.01% |
12,652
-53,908
| -81% | -$1.26M |
|
2675
Vanguard Growth ETF
VUG
$190B
| $296K | ﹤0.01% |
720
-97
| -12% | -$39.8K |
|